Mount Sinai Unveils New Comprehensive Adult Congenital Heart Disease Center
New center will help fill national gap in transition of patient care from adolescence to adulthood
Read moreIcahn School of Medicine at Mount Sinai
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a novel combination of two classes of drugs that, together, cause the highest rate of proliferation ever observed in adult human beta cells—the cells in the pancreas that produce insulin—without harming most other cells in the body. The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin.
Read moreLower Stress, Stay Optimistic, and Avoid Heart Attacks
Mount Sinai Cardiologists Talk Prevention for American Heart Month
Read moreMount Sinai Surgeons Perform First Surgery in New York City Using FDA-Approved Spinal Tethering Device
Latest technology and minimally invasive approach to correct most common form of scoliosis
Read moreResearchers Identify Opportunities to Advance Genomic Medicine
New Study Highlights Milestones in the History of Genetic Discoveries; Equitable and Fair Access Required to Address Disparities
Read moreIcahn School of Medicine at Mount Sinai Announces Recipients of Nation’s First Gender Equity Grants
Annual Distinguished Scholar Award Aims to Break Down Barriers to Equity in Medical Research
Mount Sinai Named Among Nation’s Top Health Care Employers for Diversity by Forbes
The Mount Sinai Health System has once again been ranked among America’s “Best Employers for Diversity” by Forbes and research firm Statista.
Read moreGlobal Team Enables Child With a Fatal Genetic Disease to Recover
A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.
Read morePreventing the “Silent Thief of Sight”
Mount Sinai Doctors Share Tips for Early Detection during Glaucoma Awareness Month
Read more
Mount Sinai Diversity Innovation Hub Named Among Top 50 Leaders in Digital Health for 2020
The Diversity Innovation Hub (DIH) at the Icahn School of Medicine at Mount Sinai is among the Top 50 in Digital Health for 2020.
Read moreMount Sinai Receives More Than $10 Million in Grant Funding for Brain Tumor Research
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.
Read moreResearchers Identify Potential Formula for Blood Cancer Vaccine
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.
Read more